Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Opinion Volume 5 Issue 8

Few Reflections toward the Cancer Problem

Daniel Gandia and Juan Manuel Carrera*

IQVIA, Hematology and Oncology Strategy Unit Buenos Aires, Argentina

*Corresponding Author: Juan Manuel Carrera*, IQVIA, Hematology and Oncology Strategy Unit Buenos Aires, Argentina.

Received: May 16, 2021; Published: July 21, 2021

  Cancer is an example of disease that fascinates Basic and Clinical Researchers. We don´t know at the present time, if most malignant tumors are, a) “early genetic programmed diseases”, b) the result of a random-related process of biological, chemical or physical impacts to genes during life, c) or a combination of both.


Citation: Daniel Gandia and Juan Manuel Carrera. “Few Reflections toward the Cancer Problem". Acta Scientific Medical Sciences 5.8 (2021): 42-43.


Copyright: © 2021 Daniel Gandia and Juan Manuel Carrera. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US